The Radium-select Study

计划入组 60 人 · 首次发布于 2024 年 10 月 26 日

A Phase 1/2 Study of KSQ-004EX, Autologous Tumor Infiltrating Lymphocytes Engineered to Inactivate Genes Encoding SOCS1 and Regnase-1, in Patients With Select Advanced Solid Tumors

计划入组 141 人 · 首次发布于 2024 年 9 月 19 日

First in Human Study of CDR404 in HLA-A*02:01 Participants With MAGE-A4 Expressing Solid Tumors

计划入组 42 人 · 首次发布于 2024 年 5 月 7 日

Insulin biosimilar (Sedico)

Somatropin biosimilar (Sedico)

Urokinase biosimilar (Sedico)

Medeca Pharma AB

Sweden

SIDERO BIOSCIENCE LLC

United States

Medecor Pharma, LLC

United States

Mexico City Unveils US$125 Million Biotech Investment to Build Domestic Biopharmaceutical Manufacturing Capacity

Ovarian Function Suppression Enhances Survival in Select HER2-Positive Breast Cancer

Pacritinib Gains Traction as Targeted Therapy for Myelofibrosis with Thrombocytopenia